Transarterial Chemoembolization: How 2026 "Artificial Intelligence" is Personalizing Your Tumor Understanding Transarterial Chemoembolization (TACE) as a Targeted Cancer Therapy
Transarterial chemoembolization, commonly known as TACE, is a minimally invasive medical procedure primarily used in the treatment of liver tumors, especially primary liver cancer. It is designed to deliver cancer treatment directly to the tumor while limiting exposure to the rest of the body, making it a valuable option for patients who are not suitable candidates for surgery.
In clinical practice, the growing relevance of the Transarterial Chemoembolization Market is closely linked to the increasing use of targeted, image-guided cancer therapies. During a TACE procedure, a thin catheter is guided through the blood vessels to the artery supplying the tumor. Chemotherapy drugs are then delivered directly to the tumor site, followed by embolic agents that block blood flow, helping trap the medication and deprive the tumor of oxygen and nutrients.